September 30, 2024
In the small nucleic acid drugs sub - venue from 14:20 - 14:45 on September 26th, Dr. Wang Zhong, the founder and CTO of our company, brought a wonderful lecture report titled "Innovative Synthesis Empowering the R & D and Production of New Nucleic Acid Drugs" for everyone.
Dr. Wang Zhong made industry colleagues have a deeper understanding of new nucleic acid technologies from four aspects: the technological development of small nucleic acid drugs, the challenges faced in the development of small nucleic acid drugs, new nucleic acid modifications and small nucleic acid synthesis technologies, and the advantages of Allbiosyn nucleic acid chemistry. These new nucleic acid technologies are also the core competitiveness of Allbiosyn's products and services.
With the successful conclusion of the exhibition, as we look back on this vibrant and innovative journey, our hearts are full of emotions and gains. This exhibition was like a huge stage, where numerous enterprises, experts, and practitioners gathered together to showcase the cutting - edge technologies, innovative products, and unique concepts in the industry. We witnessed the meticulous preparations and wonderful presentations of each exhibitor. This was not only a display of corporate strength, but also a vivid portrayal of the vigorous development of the entire industry.